apollo
0
Written By Urvashi Bharti , MBBS
Reviewed By Sureshvarma D , MPharma
48 Hrs returnable
COD available

Online payment accepted

Prescription drug

Whats That

tooltip

Composition :

FILGRASTIM-0.5MG

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

Expires on or after :

Apr-24
Prescription drug
 Trailing icon

Therapeutic Class

HEMATOPOIETIC

Country of origin

India
Other Info - INN0018

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Innograst Injection 0.9 ml contains 'Filgrastim' is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections.
No, Innograst Injection 0.9 ml is not recommended to patients with spleen disorder. It may cause your spleen to become enlarged, and it could rupture. If you experience pain in the left upper stomach/abdominal area or left shoulder, contact your doctor immediately.
If you are being treated for severe chronic neutropenia for a longer period, Innograst Injection 0.9 ml may cause blood in your urine (haematuria). Your doctor may regularly test your urine if you experience this side effect or if a protein is found in your urine (proteinuria).
Innograst Injection 0.9 ml should be used with caution in patients with kidney diseases. Dose adjustments may be necessary. Innograst Injection 0.9 ml cause breathlessness (dyspnoea), tachycardia & wheeze, and even death. If you have had a history of asthma, the more possibility of these systemic allergic-like reactions. Please inform your doctor.
Innograst Injection 0.9 ml to be taken with caution, especially if you have had heart problems. The dose may have to be adjusted by your doctor. In some cases, Innograst Injection 0.9 ml causes inflammation of the aorta (the large blood vessel which transports blood from the heart to the body) symptoms can include fever, abdominal pain, malaise, back pain, and increased inflammatory markers. Tell your doctor if you experience those symptoms. Please inform your doctor before taking Innograst Injection 0.9 ml.
Yes, Innograst Injection 0.9 ml may interfere with certain lab tests such as bone imaging and blood tests (elevation in lactate dehydrogenase and alkaline phosphate), possibly causing false test results. Make sure your doctor and laboratory staff know you use Innograst Injection 0.9 ml.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Caution

Avoid alcohol consumption while taking Innograst Injection 0.9 ml. It could lead to increased dizziness and drowsiness.

bannner image

Pregnancy

Caution

It is not known whether this Innograst Injection 0.9 ml will harm an unborn baby. Inform your doctor if you are pregnant or plan to become pregnant.

bannner image

Breast Feeding

Caution

It is unknown whether Innograst Injection 0.9 ml passes over into the breast milk. Please inform your doctor if you are breastfeeding before taking Innograst Injection 0.9 ml.

bannner image

Driving

Caution

Innograst Injection 0.9 ml may cause dizziness, drowsiness, and tiredness; do not drive or operate heavy machinery if you feel dizzy.

bannner image

Liver

Caution

If you have liver problems, inform your doctor before receiving Innograst Injection 0.9 ml. Your doctor may adjust the dose based on your condition or prescribe a suitable alternative.

bannner image

Kidney

Caution

Innograst Injection 0.9 ml should be used with caution in patients with kidney diseases. Dose adjustments may be necessary. In some case, Innograst Injection 0.9 ml cause kidney injury. Inform your doctor immediately if you experience puffiness in your face or ankles, blood in your urine, or brown-coloured urine, or you notice you urinate less than usual.

bannner image

Children

Safe if prescribed

Innograst Injection 0.9 ml is used to treat children who are receiving chemotherapy or who suffer from severe low white blood cell count (neutropenia). The doctor will decide the dose of Innograst Injection 0.9 ml based on the age, body weight and condition of your child.

icon image

Keep Refrigerated. Do not freeze.Prepaid payment required.

About Innograst Injection 0.9 ml

Innograst Injection 0.9 ml belongs to the class of medicine called 'hematopoietic agent' used to treat neutropenia, a lack of certain white blood cells caused by cancer, bone marrow transplant, receiving chemotherapy, bacterial infections or other conditions. Neutropenia is a condition in which the number of neutrophils (a type of white blood cell) in the blood is decreased. White blood cells (neutrophils) protect the body from infections. Without enough neutrophils, the body can not fight off bacteria which increases the risk of many types of infections.

Innograst Injection 0.9 ml contains ' Filgrastim ' that stimulates the bone marrow (the tissue where new blood cells are made) to produce more white blood cells that help fight infection. Innograst Injection 0.9 ml is used to improve white blood cells during cancer treatment (chemotherapy), bone marrow transplantation, severe chronic neutropenia (low number of a type of white blood cells), neutropenia in patients with HIV infection, and before stem cell donation.

You are advised to take Innograst Injection 0.9 ml for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side effects such as thrombocytopenia (low platelets level), anaemia (low red blood cell), headache, diarrhoea, vomiting, nausea, alopecia (unusual hair loss), tiredness, soreness, swelling of the digestive tract, fever. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

To treat your condition effectually, continue taking Innograst Injection 0.9 ml for as long as your doctor has prescribed. To avoid recurring symptoms, do not stop it midway. Do not take Innograst Injection 0.9 ml if you are pregnant or planning for pregnancy. Innograst Injection 0.9 ml should not be taken by breastfeeding mothers unless prescribed. Innograst Injection 0.9 ml should be given to children under strict medical supervision. Please tell your doctor before using Innograst Injection 0.9 ml if you have sickle cell anaemia, as Innograst Injection 0.9 ml may cause sickle cell crisis and osteoporosis (bone disease). Regular blood tests will be taken to monitor the number of white blood cells in the body. Inform your doctor about your health condition and medicines to rule out unpleasant side effects. Innograst Injection 0.9 ml is a cold chain medicine, and so it has to be stored in the refrigerator between 2-8 degrees celsius else its efficacy might get lost. Do not store in the freezer or the fridge.

Uses of Innograst Injection 0.9 ml

Neutropenia (low number of white blood neutropenia cells),  Neutropenia during Chemotherapy,  Neutropenia after Bone marrow transplantation,  Neutropenia in patients with HIV infection,  peripheral blood stem cell mobilisation (to stimulate stem cells to enter the bloodstream to be collected and used in bone marrow transplantation)

Medicinal Benefits Mweb

Medicinal Benefits

Innograst Injection 0.9 ml contains ‘Filgrastim’ is a white blood cell growth factor. It belongs to a group of proteins called cytokines and is very similar to a natural protein (granulocyte-colony stimulating factor) produced by your body. Innograst Injection 0.9 ml works by stimulating the bone marrow (the tissue where new blood cells are made) to produce more white blood cells that help fight infection. Innograst Injection 0.9 ml is used to improve white blood cells during cancer treatment (chemotherapy), bone marrow transplantation, severe chronic neutropenia (low number of a type of white blood cells), neutropenia in patients with HIV infection and before stem cell donation.

Directions for Use

Innograst Injection 0.9 ml will be administered by a healthcare professional; do not self-administer.

Side Effects of Innograst Injection 0.9 ml

  • Thrombocytopenia (low platelets level)
  • Anaemia (low red blood cell)
  • Headache
  • Diarrhoea
  • Vomiting
  • Nausea
  • Alopecia (unusual hair loss)
  • Tiredness
  • Soreness and swelling of the digestive tract
  • Fever

Drug Warnings

Do not take Innograst Injection 0.9 ml if you are allergic to Innograst Injection 0.9 ml or any of its ingredients it may contain inactive ingredients (such as dry natural rubber/latex in the needle cover on the prefilled syringe), which can cause allergic reactions or other problems. Before starting treatment with Innograst Injection 0.9 ml, inform your doctor if you have sickle cell anaemia, osteoporosis (bone disease), kidney disease, liver disease, spleen problems, heart problems, and radiation treatment. Innograst Injection 0.9 ml can cause the spleen to become enlarged, and it could rupture (tear). Inform your doctor right away if you have sudden or severe pain in your left upper stomach spreading up to your shoulder. If you receive chemotherapy or bone marrow transplant, do not use Innograst Injection 0.9 ml within 24 hours before or 24 hours after you receive chemotherapy or bone marrow transplant.  Do not take Innograst Injection 0.9 ml if you are pregnant or breastfeeding unless prescribed by the doctor. Innograst Injection 0.9 ml can be given safely to children only when prescribed. Innograst Injection 0.9 ml may cause dizziness, so drive only if you are alert. Avoid consuming alcohol along with Innograst Injection 0.9 ml as it could lead to increased drowsiness. Keep your doctor informed about all the medicines you are taking, including prescription, non-prescription medicines and herbal supplements. 

Drug-Drug Interactions Checker List

  • ALTRETAMINE
  • BUSULFAN
  • CLADRIBINE
  • PROCARBAZINE
  • PEGFILGRASTIM
  • DACARBAZINE
  • GEMTUZUMAB
  • DINUTUXIMAB
  • BEVACIZUMAB
  • ALEMTUZUMAB
  • CARBOPLATIN
  • BENDAMUSTINE

Habit Forming

No

Special Advise

  • Constantly monitors the number of blood cells in your blood, and your bone density level while you are receiving treatment with Innograst Injection 0.9 ml.

  • Do not take any kind of immunization or vaccination without your doctor's approval while using Innograst Injection 0.9 ml.

Diet & Lifestyle Advise

  • Eat a well-balanced and healthy diet, as it helps you to recover quickly. A dietitian will help you to create a diet plan based on your health condition. 

  • Avoid eating raw or undercooked food. 

  • Eat food rich in antioxidants such as berries, spinach, kidney beans, dark chocolate, etc.

  • Foods containing flavonoids help in reducing inflammation. These include soy, berries, broccoli, grapes, and green tea.

  • Limit alcohol consumption and quit smoking. 

winter care Floating Button
winter care Floating Button